GVS S.p.A.

$ 4.24 0.12 %

GVS S.p.A., alongside its subsidiaries, is a global manufacturer and distributor of advanced filtration solutions, serving diverse applications across the healthcare and life science, energy and mobility, and health and safety industries. For health and safety, the company develops air purification components for items like hand dryers, vacuum cleaners, and specialized nail station ventilation, in addition to fume extraction and HVAC systems, and a comprehensive range of personal protective equipment including masks and powered air purifying respirators. In the healthcare and life science sectors, GVS provides critical filtration technologies for medical devices such as respiratory and anesthesia equipment, autoclaves, and spirometry units, alongside liquid filtration components for IV lines and blood processing. Their offerings also encompass a broad portfolio of laboratory and diagnostic products, including various membranes, microfiltration devices, DNA/RNA test kits, and environmental monitoring solutions. For energy and mobility, GVS supplies components for automotive systems, such as fuel and engine air intake filters, SCR urea systems, ABS, ESP, and brake systems, as well as solutions for electric vehicle (EV) applications and batteries. Founded in 1979, the company initially operated as GVS S.r.l. before rebranding to GVS S.p.A. in 2001. GVS S.p.A. maintains its headquarters in Zola Predosa, Italy, and functions as a subsidiary of GVS Group S.p.A.

CEO: Massimo Scagliarini - https://www.gvs.com

Price objectif

-

Recommandation

-

DCF

$ 7.53

Loading data...

GVS.MI vs S&P500

Loading data...

No data available.

Quick ratio

1.19

suggests a healthy liquidity position, showing that the company can likely meet its short-term obligations.

P/E ratio

42.40

is considered reasonable, suggesting that the company has a valuation in line with its current profits.

EPS

0.10

is the net profit of a company divided by the number of outstanding shares, indicating the profit earned per share.

ROE

6.40 %

indicates low profitability, suggesting that the company is not using equity efficiently to generate profits.

ROIC

3.33 %

does not generate enough return to cover its financing costs, which indicates value destruction and may pose long-term profitability issues.

WACC

9.21

is a company's average cost of capital, weighted by the proportion of debt and equity in its financing. It represents the minimum return the company must generate to satisfy its investors.

Debt-to-Equity Ratio

0.77

indicates that the company uses more equity than debt, suggesting prudent management.

Free cash flow per share

0.03

is a measure of a company's financial flexibility that is determined by dividing free cash flow by the total number of shares outstanding.

Dividend payout ratio

0.00 %

the dividend payout ratio is the measure of dividends paid out to shareholders relative to the company's net income.

Earnings per share

Loading data...

No data available.

Financials

Piotroski score
7 indicates good financial health
Altman score
2.12 indicates an uncertain financial situation
Loading data...

No data available.

Cash / Debt

Cash Ratio
0.63 indicates that the company has a moderate ability to cover its short-term debts with its cash
Debt Ratio
0.38 indicates that the company uses little debt to finance its assets, suggesting good financial stability
Loading data...

No data available.

Free Cash Flow

Loading data...

No data available.

Earnings Per Share (annual)

Loading data...

No data available.

Sales

Loading data...

No data available.